Indian scientists may have found a game-changing discovery that will shorten treatment for tuberculosis to four months from the standard six-month regimen of medication
Trials included an antibiotic prescribed for infections like pneumonia have revealed.
Through the seven-year clinical trials, scientists at the National Institute for Research in Tuberculosis have found that including moxifloxacin, a potent antibiotic, in a four-month regimen proved to be better than the standard six-month treatment.
The recurrence levels were almost the same in both the regimens but patients testing negative for potential to spread TB to others was higher with the new regimen.
The results, which were shared at the recent Union World Conference on Lung health at Barcelona,
Scientists say shortening treatment duration is important.